{"nct_id":"NCT06599502","title":"A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-10-18","start_date_type":"ACTUAL","primary_completion_date":"2028-01-20","primary_completion_date_type":"ESTIMATED","completion_date":"2028-01-20","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["AZN"]}